Prevalence of the mutation C677 → T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil

American Journal of Medical Genetics

Volumn 78, Issue 4, 1998, Pages 332-335

  Arruda, Valder R ^a   Siqueira, Lucia H ^a   Gonçalves, Marilda S ^b   Von Zuben, Paula M ^a   Soares, Manoel C P ^c   Menezes, Raimundo ^c   Annichino Bizzacchi, Joyce M ^a   Costa, Fernando F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Arterial disease; Folic acid; Homocysteine; Methylenetetrahydrofolate reductase gene; Venous thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE MUTATION; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; SCHOOL CHILD; VASCULAR DISEASE; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALLELES; BRAZIL; CHILD; CYTOSINE; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC SCREENING; HOMOZYGOTE; HUMANS; INDIANS, SOUTH AMERICAN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; POLYMERASE CHAIN REACTION; THYMINE;

EID: 0031902128     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980724)78:4<332::AID-AJMG5>3.0.CO;2-N     Document Type: Article

References (32)

1. Arruda VR, von Zuben PM, Soares MCP, Menezes R, Annichino-Bizzacchi JM, Costa FF (1996): Very low incidence of Arg506 → Gln mutation in the factor V gene among the Amazonian Indians and the Brazilian black population. Thromb Haemost 75:860-861.
2. Arruda VR, von Zuben PM, Annichino-Bizzacchi JM, Costa FF (1997): The mutation Ala677 → Val in the methylenetetrahydrofolate reductase gene: A risk factor for premature arterial disease and venous thrombosis. Thromb Haemost 77:818-821.
3. Black FL, Salzano FM, Layrisse Z, Franco MHLP, Harris NS, Weimer TA (1980): Restriction and persistence of polymorphisms of HLA and other blood genetic traits in the Parakanā Indians of Brazil. Am J Phys Anthr 52:119-132.
4. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995): A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274:1049-1057.
5. Cavalli-Sforza LL, Piazza A, Menozzi P, Montain J (1988): Reconstruction of human evolution: Bringing together genetic, archaelogical and linguistic data. Proc Natl Acad Sci USA 85:6002-6006.
6. Clarke R, Daly L, Robinson K (1991): Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149-1155.
7. Curtin PD (1969): "The Slave Atlantic Trade: A Census." Milwaukee: University of Wisconsin Press.
8. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan KM, Pagan RF, Arner TG (1994): Epi Info, version 6: A word processing, database, and statistics program for epidemiology on microcomputers. Atlanta: Center for Disease Control and Prevention.
9. den Heijer M, Koster T, Blom HJ, Bos GMJ, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996): Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759-762.
10. Duncan BB, Schmidt MI, Polanczyk CA, Mengue SS (1992): High mortality rates in Brazilian adult populations-an international comparison. Rev Ass Med Brasil 38:138-144.
11. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ (1995): Thermolabile 5,10-methylenetetrahydrofolate reducttase as a cause of mild hypermocysteinemia. Am J Hum Genet 56:142-150.
12. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM (1994): High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb 14:1080-1083.
13. Franken DG, Boers GHJ, Blom HJ, Trijbels JMF, Kloppernborg PWC (1994): Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 14:465-470.
14. Froost P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GHJ, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R (1995): A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-113.
15. Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, Rozen R, Evans A, Graham IM, Whitehead ASD (1996): Homocysteine and risk of premature coronary heart disease. Circulation 94:2154-2158.
16. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N (1991): Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545.
17. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJM, Rozen RI (1996): Molecular genetic analysis in mild hyperhomocysteinemia; A common mutation in methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Human Genet 58:35-41.
18. McCully KS (1969): Vascular pathology of homocysteinemia. Am J Pathol 56:111-128.
19. McCully KS (1996): Homocysteine and vascular disease. Nature Medicine 2:386-389.
20. Millar SA, Dykes DD, Polesky HF (1988): A simple salting out procedure for extracting DNA from nucleated cell. Nucleic Acids Res 16:1215.
21. Motulsky AG (1996): Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58:17-20.
22. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP Jr, Adams MJ Jr (1996): 5,10 Methylenetetrahydofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
23. Rees DC, Cox M, Clegg JB (1995): World distribution of factor V Leiden. Lancet 346:1133-1134.
24. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988): Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
25. Stevenson RE, Schwartz CE, Du Y-Z, Adams MJ Jr (1997): Differences in methylelenetetrahydrofolate reductase geneotype frequencies, between whites and blacks. Am J Hum Genet 60:229-230.
26. Ubbink JB, Vermaak WJH, Delport R, van der Merwe A, Becker PJ, Potgieter H (1995): Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am J Clin Nutr 62:802-808.
27. U.S. Public Health Service (1992): Recommendation for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41:1-7.
28. van der Put NMJ, Steegers-Theunissen RPM, Froost P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ (1995): Mutated methylenetetrahydofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
29. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC (1996): Homocysteine metabolism and risk of myocardial infarction: Relation with vitamin B6, B12, and folate. Am J Epidemiol 143:845-859.
30. WHO Technical Report Series No. 797 (1990): "Diet Nutrition, and the Prevention of Chronic Diseases." Report of a WHO Study Group.
31. WHO Technical Report Series, No. 841 (1994): "Cardiovascular Disease Risk Factor: New Areas for Research." Report of a WHO Scientific Group.
32. Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U (1997): A single genetic origin for a common caucasian risk factor for venous thrombosis. Blood 89:397-402.